IP Library Granted Patent US 9,840,531
Granted Patent B2
US 9,840,531 · App. 15/481,942 · Granted Dec 12, 2017

Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides

Inventors: David Tellers (West Point, PA); Steven L. Colletti (West Point, PA); Vadim Dudkin (West Point, PA); Jeffrey Aaronson (West Point, PA); Aaron Momose (West Point, PA); Thomas Joseph Tucker (West Point, PA); Yu Yuan (Orlando, FL); Kathleen B. Calati (Rahway, NJ); Lu Tian (Jamison, PA); Rubina G. Parmar (West Point, PA); Anthony W. Shaw (West Point, PA); Weimin Wang (West Point, PA); Rachel Anne Storr (West Point, PA); Marina Busuek (West Point, PA); Robert A. Kowtoniuk (West Point, PA)
Assignee: Sirna Therapeutics, Inc.
C07H15/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,840,531
App. No.
15/481,942
Granted
Dec 12, 2017
Kind
B2
Abstract

Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; 4) one or more peptides independently selected from Table 3, which may be the same or different; and optionally, 5) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.

Claims (78)

1. A method for preparing a tetraGalNAc compound having a formula:

wherein:

X is —O—, —S—, or —CH 2 —; and

n, m, and q are each 1, 2, 3, or 4,

the method comprising:

reacting an azide source having the formula of

with a compound of formula

or a compound of formula

to obtain an intermediate compound;

reacting the intermediate compound with a Lys-alkyne compound of formula

to form an acetate-protected tetraGalNAc compound; and

removing the acetate protecting groups on the acetate-protected tetraGalNAc compound, thereby forming the tetraGalNAc compound.

2. The method of claim 1 , wherein the tetraGalNAc compound has the structure of

3. The method of claim 2 , wherein m is 2 and q is 1.

4. A method for preparing a tetraGalNAc compound of formula (I):

wherein:

X is —O—, —S—, or —CH 2 —; and

n is 1, 2, 3, or 4,

the method comprising:

reacting an azide source having the formula of

with a compound of formula

or a compound of formula

to obtain an intermediate compound;

reacting the intermediate compound with a Lys-alkyne compound of formula

to form an acetate-protected tetraGalNAc compound; and

removing the acetate protecting groups on the acetate-protected tetraGalNAc compound, thereby forming the tetraGalNAc compound.

5. The method of claim 4 , wherein the tetraGalNAc compound has the structure of

wherein the Lys-alkyne compound has the formula of

6. The method of claim 5 , wherein X is —O— or —CH 2 —; and n is 1, 2, or 3.

7. The method of claim 1 , wherein the reaction to obtain the intermediate compound is carried out by reacting the azide source with a compound of formula

in the presence of trifluoromethanesulfonic acid.

8. The method of claim 1 , wherein the reaction to obtain the intermediate compound is carried out by reacting the azide source with a compound of formula

in the presence of trimethylsilyl trifluoromethanesulfonate.

9. The method of claim 1 , wherein the reaction of the intermediate compound with the Lys-alkyne compound is carried out in the presence of CuBrSMe 2 .

10. The method of claim 9 , wherein the reaction of the intermediate compound with the Lys-alkyne compound is carried out in the presence of CuBrSMe 2 and diazabicycloundecene (DBU).

11. The method of claim 1 , wherein about 4 to 6 moles of the intermediate compound are added to react with each mole of the Lys-alkyne compound.

12. The method of claim 11 , wherein about 5 to 6 moles of the intermediate compound are added to react with each mole of the Lys-alkyne compound.

13. The method of claim 1 , wherein the removing the acetate protecting groups on the acetate-protected tetraGalNAc compound is carried out by reacting the acetate-protected tetraGalNAc compound with sodium methoxide.

14. The method of claim 4 , wherein the tetraGalNAc compound has the structure of

wherein the azide source is

and the Lys-alkyne compound has the formula of

15. The method of claim 14 , wherein the tetraGalNAc compound is prepared by:

reacting

with a compound of formula

in the presence of trimethylsilyl trifluoromethanesulfonate, to obtain an intermediate compound;

reacting the intermediate compound with

in the presence of CuBrSMe 2 , to form an acetate-protected tetraGalNAc compound; and

reacting the acetate-protected tetraGalNAc compound with sodium methoxide to remove the acetate protecting groups on the acetate-protected tetraGalNAc compound, thereby forming the tetraGalNAc compound.

16. The method of claim 4 , wherein the tetraGalNAc compound has the structure of

wherein the azide source is

and the Lys-alkyne compound has the formula of

17. The method of claim 14 , wherein the tetraGalNAc compound is prepared by:

reacting

with a compound of formula

in the presence of trifluoromethanesulfonic acid, to obtain an intermediate compound of formula;

reacting the intermediate compound with

in the presence of CuBrSMe 2 , to form a acetate-protected tetraGalNAc compound; and

reacting the acetate-protected tetraGalNAc compound with sodium methoxide to remove the acetate protecting groups on the acetate-protected tetraGalNAc compound, thereby forming the tetraGalNAc compound.

18. The method of claim 4 , wherein the tetraGalNAc compound has the structure of

wherein the azide source is

and the Lys-alkyne compound has the formula of

19. The method of claim 18 , wherein the tetraGalNAc compound is prepared by:

reacting

with a compound of formula

in the presence of trifluoromethanesulfonic acid, to obtain an intermediate compound;

reacting the intermediate compound with

in the presence of CuBrSMe 2 , to form an acetate-protected tetraGalNAc compound; and

reacting the acetate-protected tetraGalNAc compound with sodium methoxide to remove the acetate protecting groups on the acetate-protected tetraGalNAc compound, thereby forming the tetraGalNAc compound.

20. The method of claim 4 , wherein the tetraGalNAc compound has the structure of

wherein the azide source is

and the Lys-alkyne compound has the formula of

21. The method of claim 20 , wherein the tetraGalNAc compound is prepared by:

reacting

with a compound of formula

in the presence of trifluoromethanesulfonic acid, to obtain an intermediate compound;

reacting the intermediate compound with

in the presence of CuBrSMe 2 , to form an acetate-protected tetraGalNAc compound; and

reacting the acetate-protected tetraGalNAc compound with sodium methoxide to remove the acetate protecting groups on the acetate-protected tetraGalNAc compound, thereby forming the tetraGalNAc compound.

Assignments (1)
SECURITY INTEREST Recorded Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →
Continuity (3)
Continuation 14398369
Provisional Application 61641741 · May 2, 2012
Related Publication 20170306324A1 · Oct 26, 2017